These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 31629037)

  • 1. Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide.
    Qiu Y; Man RCH; Liao Q; Kung KLK; Chow MYT; Lam JKW
    J Control Release; 2019 Nov; 314():102-115. PubMed ID: 31629037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
    Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
    Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable and inhalable powder formulation of mRNA-LNPs using pH-modified spray-freeze drying.
    Ogawa K; Aikawa O; Tagami T; Ito T; Tahara K; Kawakami S; Ozeki T
    Int J Pharm; 2024 Nov; 665():124632. PubMed ID: 39182740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of spray-freeze-dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity.
    Okuda T; Morishita M; Mizutani K; Shibayama A; Okazaki M; Okamoto H
    J Control Release; 2018 Jun; 279():99-113. PubMed ID: 29627404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of PEGylated KL4 Peptide for siRNA Delivery with Improved Pulmonary Tolerance.
    Qiu Y; Clarke M; Wan LTL; Lo JCK; Mason AJ; Lam JKW
    Mol Pharm; 2021 Jun; 18(6):2218-2232. PubMed ID: 34014665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids.
    Liang W; Kwok PC; Chow MY; Tang P; Mason AJ; Chan HK; Lam JK
    Eur J Pharm Biopharm; 2014 Jan; 86(1):64-73. PubMed ID: 23702276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
    Meenach SA; Vogt FG; Anderson KW; Hilt JZ; McGarry RC; Mansour HM
    Int J Nanomedicine; 2013; 8():275-93. PubMed ID: 23355776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
    Meenach SA; Anderson KW; Zach Hilt J; McGarry RC; Mansour HM
    Eur J Pharm Sci; 2013 Jul; 49(4):699-711. PubMed ID: 23707466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
    Yu H; Teo J; Chew JW; Hadinoto K
    Int J Pharm; 2016 Feb; 499(1-2):38-46. PubMed ID: 26757148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spray freeze drying for dry powder inhalation of nanoparticles.
    Ali ME; Lamprecht A
    Eur J Pharm Biopharm; 2014 Aug; 87(3):510-7. PubMed ID: 24657824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery.
    Farinha S; Sá JV; Lino PR; Galésio M; Pires J; Rodrigues MÂ; Henriques J
    Pharm Res; 2023 May; 40(5):1115-1140. PubMed ID: 36456666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated pH-responsive peptide-mRNA nano self-assemblies enhance the pulmonary delivery efficiency and safety of aerosolized mRNA.
    Xu Y; Zheng Y; Ding X; Wang C; Hua B; Hong S; Huang X; Lin J; Zhang P; Chen W
    Drug Deliv; 2023 Dec; 30(1):2219870. PubMed ID: 37336779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation.
    Mohri K; Okuda T; Mori A; Danjo K; Okamoto H
    J Control Release; 2010 Jun; 144(2):221-6. PubMed ID: 20184930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
    Zimmermann CM; Baldassi D; Chan K; Adams NBP; Neumann A; Porras-Gonzalez DL; Wei X; Kneidinger N; Stoleriu MG; Burgstaller G; Witzigmann D; Luciani P; Merkel OM
    J Control Release; 2022 Nov; 351():137-150. PubMed ID: 36126785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Pulmonary Surfactant, Synthetic KL4 Peptide as Effective siRNA Delivery Vector for Pulmonary Delivery.
    Qiu Y; Chow MYT; Liang W; Chung WWY; Mak JCW; Lam JKW
    Mol Pharm; 2017 Dec; 14(12):4606-4617. PubMed ID: 29121767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability.
    Arora S; Haghi M; Young PM; Kappl M; Traini D; Jain S
    Expert Opin Drug Deliv; 2016; 13(2):183-93. PubMed ID: 26609733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual targeting powder formulation of antiviral agent for customizable nasal and lung deposition profile through single intranasal administration.
    Seow HC; Liao Q; Lau ATY; Leung SWS; Yuan S; Lam JKW
    Int J Pharm; 2022 May; 619():121704. PubMed ID: 35358643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine serum albumin as a lyoprotectant for preparation of DNA dry powder formulations using the spray-freeze drying method.
    Tsukamoto M; Okuda T; Okamoto H; Higuchi Y; Kawakami S; Yamashita F; Hashida M
    Biol Pharm Bull; 2012; 35(7):1178-81. PubMed ID: 22791169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying.
    Zhang H; Zhang Y; Williams RO; Smyth HDC
    Int J Pharm; 2021 Aug; 605():120831. PubMed ID: 34175380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.